Published in Dtsch Gesundheitsw on June 08, 1967
[Systemic effects of ultraviolet, visible and infrared radiation in serial whole body irradiation. I. Oxygen utilization, flow properties of blood, hemodynamics, blood components and phagocytosis]. Dermatol Monatsschr (1989) 1.40
Development of a solid phase enzyme immunoassay for the detection of anti-Ro autoantibodies. Scand J Rheumatol (1991) 1.39
[Determination of the antinuclear factors in lupus erythematosus]. Dermatol Wochenschr (1965) 1.06
[On the behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes of subjects with psoriasis]. Arch Klin Exp Dermatol (1967) 0.97
[Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein]. Dermatol Monatsschr (1976) 0.93
[Characteristics of psoriasis in childhood]. Dermatol Monatsschr (1979) 0.92
[Antinuclear factors in psoriasis vulgaris. (Preliminary report)]. Dermatol Wochenschr (1965) 0.91
Lymphocyte transformation tests in patients under treatment with immunosuppressive drugs. Helv Med Acta (1969) 0.90
[Immunologic and clinical studies on psoriasis]. Dtsch Gesundheitsw (1966) 0.89
[Pathogenesis and nosologic status of psoriatic arthropathy]. Hautarzt (1971) 0.89
Stable lipid peroxidation products in human skin: detection, ultraviolet light-induced increase, pathogenic importance. Experientia (1976) 0.88
[Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin]. Dermatol Monatsschr (1977) 0.87
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol (1998) 0.86
Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum (1994) 0.85
[Studies on the excretion of tryptophan metabolites in patients with circumscript and progressive scleroderma]. Dermatol Wochenschr (1968) 0.85
[Electron microscopy studies in lichen sclerosus and antrophicus]. Dermatol Monatsschr (1972) 0.85
[Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1985) 0.84
Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet (1991) 0.83
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
[Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo]. Dermatol Monatsschr (1983) 0.82
[The lymphocyte transformation test in squamous epithelial carcinomas of the orofacial region]. Zahn Mund Kieferheilkd Zentralbl (1977) 0.82
[Studies on the pathogenesis of acrodermatitis enteropathica Danbolt-Closs]. Arch Klin Exp Dermatol (1967) 0.81
Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice. Exp Clin Endocrinol (1986) 0.81
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Lymphocyte transformation test in bullous dermatoses]. Dermatol Monatsschr (1977) 0.81
[Immunological studies on the nosology of psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.80
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. Contact Dermatitis (1992) 0.80
Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment. Br J Dermatol (1983) 0.80
A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernatants of lymphocyte cultures and human hybridomas. Biomed Biochim Acta (1986) 0.80
[Clinical manifestations and diagnosis of penicillin allergy and other penicillin side effects]. Dermatol Monatsschr (1969) 0.80
[On the evidence of antinuclear factors in various forms fof psoriasis]. Arch Klin Exp Dermatol (1966) 0.79
[Stabilization of the erythrocyte membrane with UVA-irradiation using 8-methoxypsoralen]. Dermatol Monatsschr (1980) 0.79
[Differentiation of the antipsoriatic and phototoxic effectiveness of topical PUVA therapy]. Hautarzt (1986) 0.79
[Epilepsy as an early symptom of lupus erythematosus]. Dermatol Wochenschr (1965) 0.79
[Transitory acantholytic dermatosis (Grover) in an HIV infected patient]. Z Hautkr (1990) 0.79
Polyclonal B cell activation in the acute phase of systemic lupus erythematosus--aspects of pathogenic significance. J Invest Dermatol (1982) 0.78
[Inactivation and protection of phosphofructokinase during 8-methoxypsoralen and UVA-treatment]. Dermatol Monatsschr (1980) 0.78
[Destruction of peripheral lymphocytes by 8-MOP and UVA]. Dermatol Monatsschr (1980) 0.78
Investigations into Ro-specific antibody-associated congenital cardiac conduction defects. Clin Investig (1992) 0.78
[Liver involvement in erythropoietic protoporphyria]. Dermatol Monatsschr (1974) 0.78
[Human susceptibility to herpesvirus suis (Aujeszky-virus). 4. Serological determinations in persons in infection endangered occupational groups]. Z Gesamte Hyg (1970) 0.77
[Recent studies on antinuclear factors with special reference to differential diagnostic and genetic viewpoints]. Z Gesamte Inn Med (1967) 0.77
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol (1995) 0.77
Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay. J Autoimmun (1994) 0.77
[Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis]. Z Rheumatol (1991) 0.77
[Comparative studies of senstive chronaxy in various forms of scleroderma and lichen sclerosus et atrophicus]. Dermatol Wochenschr (1968) 0.77
[Familial studies in lupus erythematosus]. Dermatol Wochenschr (1965) 0.77
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol (1994) 0.77
[On the problem of demonstration of antinuclear factors in scleroderma patients]. Dermatol Wochenschr (1966) 0.77
[Experiences with vitamin A acid treatment in Ichthyosis congenita larvata and Erythroderma ichthyosiforme congenitum]. Dermatol Monatsschr (1974) 0.77
The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus. Arch Dermatol Res (1987) 0.76
[Differential diagnostic studies on lupus erythematosus chronicus discoides and lymphocyte infiltration Jessner-Kanof using the immunofluorescent technic]. Arch Klin Exp Dermatol (1968) 0.76
Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells. Arch Dermatol Res (1993) 0.76
[Electron microscopy examinations of the muscular tissue in psoriasis arthropathica]. Dermatol Monatsschr (1971) 0.76
[Electron microscopy studies of the muscles in lupus erythematosus]. Dermatol Monatsschr (1973) 0.76
[The role of immunofluorescence methods in dermatology (technic and clinical use)]. Dermatol Monatsschr (1970) 0.76
[Electron microscopy studies on the demonstration of virus-like particles in dermatomyositis]. Dermatol Monatsschr (1973) 0.76
Cis-urocanic acid as a mediator of ultraviolet-light-induced immunosuppression. Semin Hematol (1992) 0.76
[Experiences with long-term immunosuppressive therapy of connnective tissue diseases]. Z Gesamte Inn Med (1974) 0.75
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res (1990) 0.75
[Studies on the currently increased incidence and on the clinical aspects and therapy of scabies]. Dtsch Gesundheitsw (1970) 0.75
[Drug hypersensitivity in lupus erythematosus]. Allerg Asthma (Leipz) (1967) 0.75
[Studies on the kidney involvement in lupus erythematodes chronicus]. Dermatol Monatsschr (1970) 0.75
[Current penicillin therapy of syphilis from a critical viewpoint]. Z Arztl Fortbild (Jena) (1971) 0.75
[Present knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. I. Pathogenesis of common psoriasis]. Dtsch Gesundheitsw (1970) 0.75
[Animal experiment studies on the determination of sensitivity capacity of chemical compounds. 3. Results following sensitization with dinitrochlorobenzene and final evaluation]. Dermatol Monatsschr (1974) 0.75
[Tryptophan and tyrosine administration in acrodermatitis enteropathica (Danbolt)]. Klin Wochenschr (1967) 0.75
[Allergic diseases of the skin]. Z Arztl Fortbild (Jena) (1971) 0.75
[Indications and contraindications for the interruption in dermatologic diseases (author's transl)]. Ther Umsch (1974) 0.75
[Experiences with combined long term therapy of psoriasis arthropathica using antimetabolites and steroids]. Dermatol Monatsschr (1974) 0.75
[Drug sensitization in lupus erythematosus patients]. Allerg Asthma (Leipz) (1967) 0.75
[Autoimmunology studies in psoriasis patients]. Dermatol Monatsschr (1969) 0.75
[On the pathogenesis of medicamentous exanthema]. Z Arztl Fortbild (Jena) (1967) 0.75
[Morphological and biochemical findings in multiple nevoxanthoendothelioma]. Hautarzt (1967) 0.75
[Diagnostic criteria in lupus erythematosus with special reference to skin changes]. Dermatol Monatsschr (1971) 0.75
[Virus-like structures in the skin and kidneys of patients with chronic and visceral lupus erythematosus. Electron microscope study]. Vestn Dermatol Venerol (1974) 0.75
[Present tasks and problems in the research of psoriasis]. Dermatol Monatsschr (1970) 0.75
[Electron microscopic study of the bone marrow in chronic discoid and systemic lupus erythematosus]. Dermatol Monatsschr (1974) 0.75
[Studies of muscle changes in chronic lupus erythematosus]. Arch Klin Exp Dermatol (1967) 0.75
[Treatment of arthropathic psoriasis with antimetabolites and glucocorticoids]. Dermatol Monatsschr (1971) 0.75
[Studies on the increase of scabies. II. Clinical aspects and epidemiology of the current scabies epidemics]. Dermatol Monatsschr (1971) 0.75
[Current viewpoints on the pathogenesis of lupus erythematosus]. Z Arztl Fortbild (Jena) (1971) 0.75
[Comparative infrared determinations of the rewarming of the skin in endogenous and atopic eczema]. Dermatol Monatsschr (1971) 0.75
[Significance of scabies in childhood]. Padiatr Grenzgeb (1974) 0.75
[External therapy at the Hospital for Dermatology in Berlin]. Dermatol Monatsschr (1974) 0.75
[Lupus erythematodes in childhood--a virus-induced autoimmune disease?]. Padiatr Grenzgeb (1974) 0.75
[Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs]. Dtsch Gesundheitsw (1970) 0.75
[The problems of autoimmunization as basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[75th birthday of Professor Dr. Dr. h. c. Karl Linser]. Przegl Dermatol (1971) 0.75
[Studies on the demonstration and the transferability of cellular antibodies in drug-induced exanthema]. Dermatol Wochenschr (1967) 0.75
[Clinical and morphologic peculiarities in simultaneous occurrence of lupus erythematodes and exanthema from drugs]. Z Haut Geschlechtskr (1966) 0.75